Tr1X, Inc. (pronounced “Trix”), a clinical-stage biopharmaceutical company developing first-in-class allogeneic engineered ...

Founded by leading scientists who discovered Tr1 cells, Tr1X develops off-the-shelf, allogeneic Treg and CAR-Treg therapies engineered for superior safety, scalability and accessibility, eliminating ...

Founded by leading scientists who discovered Tr1 cells, Tr1X develops off-the-shelf, allogeneic Treg and CAR-Treg therapies engineered for superior safety, scalability and accessibility ...